GO:0043068 positive regulation of programmed cell death: Cell Death Signaling, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0043068 describes any process that activates or increases the frequency, rate or extent of programmed cell death, a genetically controlled form of cell death driven by endogenous cellular machinery.
• Programmed cell death is executed through multiple pathways, including apoptosis, ferroptosis, pyroptosis and autophagic cell death, each with distinct molecular regulators [4,5,7].
• BCL-2 family proteins are central regulators of apoptosis, balancing pro-death and pro-survival signals to determine cell fate.
• Ferroptosis is an iron-dependent, lipid-peroxidation-driven form of programmed cell death regulated by ACSL4, GPX4 and mitochondrial proteins such as VDAC1 [1,2,8].
• Pyroptosis is mediated by gasdermin family proteins, including gasdermin E (GSDME), which can be stabilized by USP48 to promote cell death in cancer.
• Dysregulation of programmed cell death contributes to cancer, neurodegeneration, autoimmune diseases and therapy resistance, making it a major therapeutic target [4,6].
Description
Programmed cell death (PCD) is a genetically encoded process that eliminates damaged, infected or superfluous cells, and its positive regulation (GO:0043068) encompasses all molecular events that activate or increase the frequency, rate or extent of this death. Unlike accidental necrosis, PCD depends on endogenous cellular machinery and is tightly controlled by signaling networks that sense developmental cues, stress, immune signals and metabolic imbalances [4,5]. The term GO:0043068 is therefore a hub for understanding how cells commit to death and how this commitment can be therapeutically modulated. The importance of positive regulation of PCD is underscored by its roles in cancer suppression, immune homeostasis and tissue remodeling [4,6]. For example, BCL-2 family proteins integrate pro-apoptotic and pro-survival signals to decide whether a cell dies, and their imbalance is a hallmark of many cancers. Beyond apoptosis, ferroptosis and pyroptosis are distinct PCD modalities that are positively regulated by lipid metabolism enzymes (e.g., ACSL4), mitochondrial proteins (e.g., VDAC1) and inflammatory caspases/gasdermins [1,2,7]. Understanding these pathways at the molecular level is essential for developing targeted therapies that selectively kill cancer cells or protect neurons from inappropriate death [4,6].
positive regulation of programmed cell death At A Glance
| GO ID | GO:0043068 |
|---|---|
| GO term | positive regulation of programmed cell death |
| Ontology | biological_process |
| Definition | Any process that activates or increases the frequency, rate or extent of programmed cell death, cell death resulting from activation of endogenous cellular processes. |
| Synonyms | activation of programmed cell death; positive regulation of non-apoptotic programmed cell death; stimulation of programmed cell death; up regulation of programmed cell death; up-regulation of programmed cell death; upregulation of programmed cell death |
| Major function | Activation or amplification of genetically controlled cell death pathways, including apoptosis, ferroptosis, pyroptosis and autophagic cell death. |
| Related processes | Apoptosis, ferroptosis, pyroptosis, autophagic cell death, immune cell killing, developmental cell death. |
| Key regulators | BCL-2 family proteins, caspases, ACSL4, GPX4, VDAC1, gasdermins, USP48, phospholipid phosphatases. |
| Disease relevance | Cancer, neurodegeneration, autoimmune diseases, ischemia-reperfusion injury, therapy resistance. |
What Is GO:0043068?
GO:0043068, positive regulation of programmed cell death, is defined as any process that activates or increases the frequency, rate or extent of programmed cell death, which is cell death resulting from activation of endogenous cellular processes. In other words, it includes all signaling events, molecular interactions and biochemical modifications that promote a cell's intrinsic death program, whether through apoptosis, ferroptosis, pyroptosis, autophagic cell death or other regulated death modalities [4,5,7].
Why Is positive regulation of programmed cell death Important in Cell Biology?
Positive regulation of programmed cell death is fundamental to development, tissue homeostasis and immunity, and its dysregulation underlies numerous human diseases. Understanding how cells activate death programs provides mechanistic insight into cancer biology, where evasion of apoptosis or ferroptosis promotes tumor survival and therapy resistance [4,6,8]. Conversely, excessive or inappropriate PCD contributes to neurodegeneration and ischemic injury, making its positive regulators attractive targets for both pro-death cancer therapies and pro-survival neuroprotective strategies [4,6].
• Tumor suppression: activation of apoptosis or ferroptosis can eliminate malignant cells and overcome drug resistance [4,8].
• Immune surveillance: cytotoxic T cells and natural killer cells induce PCD in target cells, and PD-1 signaling can limit T cell ferroptosis, affecting antitumor immunity.
• Neurodegeneration: aberrant activation of PCD contributes to neuronal loss in Alzheimer's, Parkinson's and other neurodegenerative diseases.
• Ischemia-reperfusion injury: ferroptosis and apoptosis are major drivers of tissue damage after stroke or myocardial infarction [1,5].
• Inflammation: pyroptosis releases inflammatory cytokines and DAMPs, linking PCD to innate immunity and inflammatory diseases.
• Developmental biology: programmed cell death sculpts tissues and eliminates superfluous cells during embryogenesis.
• Cancer therapy: many chemotherapies and radiotherapies act by inducing PCD, and resistance often involves its suppression [4,6].
• Metabolic regulation: lipid metabolism and iron homeostasis directly control ferroptosis sensitivity [1,2,8].
• Therapeutic targeting: small molecules and biologics that modulate PCD regulators are in clinical development [4,7].
• Biomarker discovery: expression of PCD-related genes can predict prognosis and guide treatment selection.
What Happens During positive regulation of programmed cell death?
Initiation of death signaling
In simple terms: The cell receives a signal that tells it to die.
Positive regulation of programmed cell death begins when death ligands, stress signals or developmental cues activate specific receptors and sensors. For apoptosis, the BCL-2 family proteins integrate these signals; pro-apoptotic BH3-only proteins (e.g., BIM, PUMA) are activated and neutralize pro-survival BCL-2 proteins, leading to Bax/Bak activation. In ferroptosis, initiation involves inhibition of the cystine/glutamate antiporter or GPX4 inactivation, leading to lipid peroxidation [1,8]. Pyroptosis is initiated by inflammasome-mediated caspase-1 activation or caspase-3 cleavage of gasdermin E.
Mitochondrial outer membrane permeabilization (MOMP)
In simple terms: The mitochondria decide to release death-promoting factors.
In the intrinsic apoptosis pathway, activated Bax and Bak oligomerize on the mitochondrial outer membrane, causing MOMP and release of cytochrome c, SMAC/DIABLO and other pro-apoptotic factors. This step is considered the point of no return and is tightly regulated by BCL-2 family proteins. Ferroptosis also involves mitochondrial dysfunction, with VDAC1 oligomerization contributing to mitochondrial injury and death.
Executioner caspase activation
In simple terms: Enzymes called caspases dismantle the cell.
Cytochrome c release leads to apoptosome formation and activation of initiator caspase-9, which then cleaves executioner caspases-3 and -7. These executioner caspases cleave hundreds of substrates, leading to DNA fragmentation, membrane blebbing and cell disassembly. In pyroptosis, inflammatory caspases (caspase-1, -4/-5/-11) or caspase-3 cleave gasdermins (e.g., GSDME) to form membrane pores and induce lytic death.
Lipid peroxidation and ferroptosis execution
In simple terms: Fats in the cell membrane become damaged, killing the cell.
Ferroptosis is driven by iron-dependent lipid peroxidation. ACSL4 promotes the incorporation of polyunsaturated fatty acids into membrane phospholipids, making them susceptible to oxidation. GPX4 normally detoxifies lipid peroxides, and its inhibition or degradation leads to ferroptotic death. Mitochondrial proteins such as VDAC1 modulate ferroptosis sensitivity, and VSTM2L protects cells by inhibiting VDAC1 oligomerization.
Autophagic cell death and lysosomal degradation
In simple terms: The cell digests itself through autophagy.
Autophagic cell death is a form of programmed cell death that depends on autophagy machinery. Ferroptosis has been shown to be an autophagic cell death process, as inhibition of autophagy limits ferroptotic death in some contexts. This highlights crosstalk between autophagy and other PCD pathways.
Phagocytic clearance and immune activation
In simple terms: Dead cells are cleared and can alert the immune system.
After PCD, dying cells expose 'eat-me' signals such as phosphatidylserine, leading to phagocytic clearance. In pyroptosis, membrane pores release inflammatory contents that activate immune responses. In ferroptosis, oxidized lipids and DAMPs can modulate immune cell function, and PD-1 signaling limits phospholipid phosphatase 1 expression, promoting intratumoral CD8+ T cell ferroptosis.
Key Genes Involved in GO:0043068 positive regulation of programmed cell death
The following genes and proteins are key regulators or effectors of positive regulation of programmed cell death, with established roles in apoptosis, ferroptosis, pyroptosis or autophagic cell death.
| Gene | Major Role | Research Relevance |
|---|---|---|
| BCL2 | Anti-apoptotic; inhibits Bax/Bak activation | Target for cancer therapy; overexpression blocks PCD |
| BAX | Pro-apoptotic; forms pores in mitochondria | Knockout reduces apoptosis; key effector of MOMP |
| BAK | Pro-apoptotic; redundant with Bax | Double knockout with Bax blocks intrinsic apoptosis |
| CASP3 | Executioner caspase; cleaves substrates | Central to apoptosis execution; knockout viable but defective |
| CASP8 | Initiator caspase in extrinsic apoptosis | Mediates death receptor-induced apoptosis |
| ACSL4 | Promotes lipid peroxidation; essential for ferroptosis | Knockout confers ferroptosis resistance |
| GPX4 | Detoxifies lipid peroxides; inhibits ferroptosis | Inhibition or knockdown induces ferroptosis |
| VDAC1 | Mitochondrial porin; oligomerization promotes ferroptosis | Target of VSTM2L; regulates mitochondrial homeostasis |
| GSDME | Gasdermin E; forms pores in pyroptosis | Cleaved by caspase-3; stabilized by USP48 |
| USP48 | Deubiquitinase; stabilizes GSDME | Promotes pyroptosis in cancer |
| PLPP1 | Phospholipid phosphatase 1; modulates ferroptosis | Downregulated by PD-1 signaling in T cells |
| FASN | Fatty acid synthase; inhibits ferroptosis via GPX4 regulation | Palmitoylation-dependent regulation of GPX4 |
| USP5 | Deubiquitinase; regulates GPX4 stability | Involved in FASN-mediated ferroptosis inhibition |
| VSTM2L | Inhibits VDAC1 oligomerization; protects against ferroptosis | Overexpression protects prostate cancer cells |
| BID | BH3-only protein; links extrinsic and intrinsic apoptosis | Cleaved by caspase-8 to activate Bax/Bak |
| PMAIP1 (NOXA) | BH3-only protein; sensitizes to apoptosis | Transcriptional target of p53 |
| BBC3 (PUMA) | BH3-only protein; promotes apoptosis | Key mediator of p53-induced apoptosis |
| ATG5 | Autophagy-related; required for autophagic cell death | Knockout blocks ferroptosis in some contexts |
How Is positive regulation of programmed cell death Regulated?
Positive regulation of programmed cell death is controlled at multiple levels. Transcriptional regulation by p53 induces pro-apoptotic BCL-2 family members such as PUMA and NOXA. Post-translational modifications, including ubiquitination and deubiquitination, modulate the stability of key effectors: USP48 stabilizes GSDME to promote pyroptosis, while USP5 regulates GPX4 deubiquitination in a FASN-dependent manner to inhibit ferroptosis. Metabolic signals also play a role; ACSL4-mediated lipid remodeling sensitizes cells to ferroptosis, and PD-1 signaling downregulates PLPP1 to promote T cell ferroptosis. Mitochondrial dynamics and VDAC1 oligomerization are additional control points, as VSTM2L inhibits VDAC1 oligomerization to protect cells.
positive regulation of programmed cell death and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| BCL2 | Lymphoma, leukemia; apoptosis evasion | BCL2 overexpression knock-in in cancer cell lines; KO for sensitivity |
| ACSL4 | Ferroptosis-related neurodegeneration, cancer | ACSL4 KO cells for ferroptosis resistance; point mutations in catalytic domain |
| GPX4 | Cancer, neurodegeneration; ferroptosis regulation | GPX4 KO or inducible knockdown; overexpression for protection |
| GSDME | Inflammatory diseases, cancer; pyroptosis | GSDME KO cells; knock-in of cleavage-resistant mutant |
| VDAC1 | Prostate cancer, mitochondrial dysfunction | VDAC1 KO or oligomerization-deficient mutants; VSTM2L overexpression |
Cancer
Evasion of programmed cell death is a hallmark of cancer. Overexpression of anti-apoptotic BCL-2 proteins or loss of pro-apoptotic effectors (e.g., Bax) confers resistance to chemotherapy. Ferroptosis suppression via GPX4 upregulation or ACSL4 downregulation also promotes tumor survival [1,8]. Conversely, inducing ferroptosis or pyroptosis is a promising strategy to kill therapy-resistant cancer cells [7,8]. Prognostic models incorporating immune-related cell death genes have been developed for colorectal cancer, linking PCD to macrophage phenotypic evolution.
Neurodegeneration
Excessive activation of programmed cell death contributes to neuronal loss in Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis. BCL-2 family dysregulation and caspase activation are observed in affected neurons. Ferroptosis has emerged as a key driver of neurodegeneration due to iron accumulation and lipid peroxidation in the brain.
Ischemia-reperfusion injury
Following stroke or myocardial infarction, restoration of blood flow triggers programmed cell death, including apoptosis and ferroptosis, exacerbating tissue damage. Inhibiting ferroptosis via ACSL4 or GPX4 modulation has shown protective effects in preclinical models [1,5].
Inflammatory and autoimmune diseases
Pyroptosis, mediated by gasdermins, releases inflammatory cytokines and DAMPs, contributing to sepsis, inflammatory bowel disease and autoimmune conditions. Modulating GSDME or upstream caspases may offer therapeutic benefit.
From positive regulation of programmed cell death-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of a candidate gene inhibit programmed cell death? | CRISPR knockout cell lines (e.g., ACSL4, GPX4, BAX) [1,4,8] |
| Does a specific mutation alter pro-death activity? | Point mutation knock-in (e.g., catalytic dead ACSL4, caspase cleavage site mutant) [1,7] |
| Does overexpression of a protective gene block PCD? | Overexpression models (e.g., VSTM2L, BCL2) [2,4] |
| How does a gene fusion or tag affect protein localization during PCD? | Tagged knock-in (e.g., GFP-GSDME, HA-GPX4) [7,8] |
| Can a gene signature predict prognosis? | Bioinformatics analysis of patient cohorts (e.g., colorectal cancer) |
| Does PD-1 signaling regulate T cell ferroptosis? | In vivo mouse models and primary T cell cultures |
How to Study the positive regulation of programmed cell death Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Annexin V/PI flow cytometry | Phosphatidylserine exposure and membrane integrity | Apoptosis quantification |
| Caspase-3/7 activity assay | Executioner caspase activity | Apoptosis induction |
| C11-BODIPY staining | Lipid peroxidation | Ferroptosis detection [1,8] |
| LDH release assay | Membrane pore formation | Pyroptosis measurement |
| CRISPR knockout library screen | Gene essentiality for PCD | Identification of novel regulators [1,8] |
| Immunoblotting | Protein cleavage and expression | Gasdermin cleavage, BCL-2 family levels [4,7] |
| Live-cell imaging | Real-time death dynamics | Mitochondrial permeabilization, pore formation [2,4] |
| RNA-seq / bioinformatics | Transcriptional signatures | Prognostic models, pathway enrichment |
Cell death assays
Multiple assays are used to measure positive regulation of programmed cell death. Apoptosis is commonly assessed by Annexin V/PI staining, caspase-3/7 activity assays, and TUNEL staining for DNA fragmentation. Ferroptosis is measured by lipid peroxidation sensors (e.g., C11-BODIPY), iron chelation rescue, and GPX4 activity assays [1,8]. Pyroptosis is detected by gasdermin cleavage immunoblotting and LDH release assays.
Genetic screens and CRISPR libraries
Genome-wide CRISPR knockout or activation screens can identify positive regulators of PCD. For example, screens for ferroptosis inducers have identified ACSL4 and GPX4 [1,8]. Libraries targeting kinases, ubiquitinases or metabolic genes can reveal novel regulators. Bioinformatics analysis of screen hits using GO enrichment highlights pathways such as programmed cell death.
Proteomics and interactomics
Mass spectrometry-based proteomics can identify protein complexes and post-translational modifications during PCD. For instance, USP48-mediated stabilization of GSDME was discovered through ubiquitin proteomics. Proximity labeling or co-immunoprecipitation can map interactions among BCL-2 family proteins.
Imaging and live-cell analysis
Live-cell imaging with fluorescent reporters (e.g., cytochrome c-GFP, GSDME-GFP) allows real-time visualization of PCD execution. Mitochondrial membrane potential dyes (TMRE) and lipid peroxidation sensors track MOMP and ferroptosis [2,4]. These methods are essential for understanding the spatiotemporal dynamics of positive regulation of PCD.
How CRISPR Can Be Used to Study GO:0043068 positive regulation of programmed cell death
Knockout
CRISPR knockout is widely used to study positive regulation of programmed cell death by deleting candidate genes. For example, ACSL4 knockout confers resistance to ferroptosis, and GPX4 knockout sensitizes cells to lipid peroxidation. BAX/BAK double knockout blocks intrinsic apoptosis. Knockout of GSDME reduces pyroptosis. These models help establish causality.
Point Mutation
Point mutation knock-in allows precise interrogation of catalytic residues, phosphorylation sites or cleavage sites. For instance, mutation of the caspase-3 cleavage site in GSDME prevents pyroptosis. Catalytic dead mutants of ACSL4 can distinguish enzymatic from scaffolding functions. Such models are valuable for dissecting molecular mechanisms.
Knock-in
Knock-in of tagged or reporter genes enables visualization and tracking of PCD regulators. GFP-GSDME knock-in allows live imaging of pore formation. HA-GPX4 knock-in facilitates immunoprecipitation and proteomics. Knock-in of disease-associated mutations (e.g., in BCL2) can model cancer resistance.
Overexpression
Overexpression models are used to test whether a gene is sufficient to promote or inhibit PCD. Overexpression of VSTM2L protects prostate cancer cells from ferroptosis by inhibiting VDAC1 oligomerization. BCL2 overexpression blocks apoptosis and is a common mechanism of chemoresistance. FASN overexpression inhibits ferroptosis via USP5-mediated GPX4 stabilization.
How EDITGENE Supports positive regulation of programmed cell death Research
Researchers studying positive regulation of programmed cell death-related genes often need to determine whether a candidate gene is causally involved in death signaling, and whether its loss or gain of function alters cell fate. EDITGENE provides comprehensive CRISPR-based services to generate precisely engineered cell models for such investigations.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of programmed cell death research.
Frequently Asked Questions About positive regulation of programmed cell death
What is GO:0043068?
GO:0043068 is the Gene Ontology term for positive regulation of programmed cell death, defined as any process that activates or increases the frequency, rate or extent of programmed cell death, a genetically controlled cell death driven by endogenous cellular processes.
What genes are involved in positive regulation of programmed cell death?
Key genes include BCL2, BAX, BAK, CASP3, CASP8, ACSL4, GPX4, VDAC1, GSDME, USP48, PLPP1, FASN and USP5, among others [1,2,3,4,7,8].
How is programmed cell death regulated?
It is regulated by BCL-2 family proteins, caspases, ubiquitination/deubiquitination, lipid metabolism and immune signaling pathways such as PD-1 [3,4,7,8].
What is the difference between apoptosis and ferroptosis?
Apoptosis is caspase-dependent and mediated by BCL-2 family proteins, while ferroptosis is iron-dependent and driven by lipid peroxidation, regulated by ACSL4 and GPX4 [1,4,8].
What is pyroptosis?
Pyroptosis is an inflammatory form of programmed cell death mediated by gasdermin proteins, such as GSDME, which form membrane pores.
How can I study positive regulation of programmed cell death in the lab?
Common methods include CRISPR knockout screens, Annexin V staining, caspase activity assays, lipid peroxidation sensors and live-cell imaging [1,4,7,8].
What diseases are associated with dysregulated programmed cell death?
Cancer, neurodegeneration, ischemia-reperfusion injury and inflammatory diseases are linked to abnormal PCD [1,4,6,7].
What is the role of ACSL4 in ferroptosis?
ACSL4 promotes the incorporation of polyunsaturated fatty acids into membrane phospholipids, making cells susceptible to lipid peroxidation and ferroptosis.
How does GPX4 inhibit ferroptosis?
GPX4 detoxifies lipid peroxides; its inhibition or degradation leads to ferroptotic cell death.
Can CRISPR be used to study programmed cell death?
Yes, CRISPR knockout, knock-in and overexpression models are widely used to dissect gene function in PCD pathways [1,2,7,8].
Conclusion
Positive regulation of programmed cell death (GO:0043068) is a central biological process that controls cell fate through diverse molecular pathways, including apoptosis, ferroptosis, pyroptosis and autophagic cell death. Its dysregulation is implicated in cancer, neurodegeneration and inflammatory diseases, making it a prime target for therapeutic intervention [4,6,7]. Advances in CRISPR-based models and bioinformatics are accelerating the discovery of novel regulators and their translation into clinical strategies [1,2,8].
References
- 1. Ding K et al.. 2023. Acyl-CoA synthase ACSL4: an essential target in ferroptosis and fatty acid metabolism.. Chin Med J (Engl) 136(21):2521-2537 PMID: 37442770
- 2. Yang J et al.. 2025. VSTM2L protects prostate cancer cells against ferroptosis via inhibiting VDAC1 oligomerization and maintaining mitochondria homeostasis.. Nat Commun 16(1):1160 PMID: 39880844
- 3. Ping Y et al.. 2024. PD-1 signaling limits expression of phospholipid phosphatase 1 and promotes intratumoral CD8(+) T cell ferroptosis.. Immunity 57(9):2122-2139.e9 PMID: 39208806
- 4. Singh R et al.. 2019. Regulation of apoptosis in health and disease: the balancing act of BCL-2 family proteins.. Nat Rev Mol Cell Biol 20(3):175-193 PMID: 30655609
- 5. Gao M et al.. 2016. Ferroptosis is an autophagic cell death process.. Cell Res 26(9):1021-32 PMID: 27514700
- 6. Liu H et al.. 2025. Prognostic models of immune-related cell death and stress unveil mechanisms driving macrophage phenotypic evolution in colorectal cancer.. J Transl Med 23(1):127 PMID: 39875913
- 7. Ren Y et al.. 2023. USP48 Stabilizes Gasdermin E to Promote Pyroptosis in Cancer.. Cancer Res 83(7):1074-1093 PMID: 36607699
- 8. Qian Z et al.. 2025. FASN inhibits ferroptosis in breast cancer via USP5 palmitoylation-dependent regulation of GPX4 deubiquitination.. J Exp Clin Cancer Res 44(1):289 PMID: 41088402
